Replies to post #137129 on Biotech Values

[mcbio]

MYRX is loaded with cash about $3.70 +/- a share net depending how much they burned since last 10q on 9/30/11 - I was suspecting a reverse merger to be honest like NOVC did with Trancept (now TSPT)© 2012 InvestorsHub.Com, Inc.

That cash is only going to continue to dwindle going forward though. And if there's nothing of interest to a prospective partner/suitor in the pipeline, and I kind of wonder on that point given their need to bring in a third-party to gauge interest, then I question how much upside there is.